Evidence map›Paper›PMID 42171605›Full record

ArticleJCI insight2026

Exhausted T cell phenotypes in disseminated coccidioidomycosis.

Gregory D Whitehill, Alexis V Stephens, Timothy J Thauland, Miguel A Moreno Lastre, Matthew M Tate, Sinem Beyhan, Royce H Johnson, George R Thompson, Maria Garcia-Lloret, Manish J Butte

Abstract read
In one paragraph

Article in JCI insight, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Gregory D WhitehillDepartment of Medicine, Division of Infectious Diseases.
Alexis V StephensDepartment of Human Genetics, and.
Timothy J ThaulandDepartment of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los Angeles, California, USA.
Miguel A Moreno LastreDepartment of Pediatrics, Division of Immunology, Allergy, and Rheumatology, UCLA, Los Angeles, California, USA.
Matthew M TateVeterans Affairs San Diego Healthcare System, Research Service, San Diego, California, USA.
Sinem BeyhanVeterans Affairs San Diego Healthcare System, Research Service, San Diego, California, USA.
Royce H JohnsonDepartment of Medicine, Division of Infectious Diseases.
George R ThompsonDepartment of Medicine, Division of Infectious Diseases, and.
Maria Garcia-LloretDepartment of Human Genetics, and.
Manish J ButteDepartment of Human Genetics, and.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUNDCoccidioidomycosis ranges from self-limiting uncomplicated Valley fever (UVF) in most cases to life-threatening disseminated coccidioidomycosis (DCM) in rare individuals. A few patterns of immunologic deficits allowing for dissemination have been identified, although the specific defects in most individuals with DCM remain undefined. We hypothesized that chronic antigen exposure in DCM engenders a state of T cell exhaustion.METHODSFrom a cohort of over 300 individuals with confirmed diagnoses of coccidioidomycosis, circulating T cell phenotypes were characterized via flow cytometry and Coccidioides-specific T cell responses were measured by activation-induced marker (AIM) assay.RESULTSMale sex was significantly associated with disseminated disease (OR 2.5, 95% CI 1.5-4.0). A majority (52%) of individuals showed Coccidioides-specific T cell responses in our AIM assay. We noted a significant difference in patients sampled in the first year of diagnosis, where only 8% of patients with DCM had T cell responses during this time, as compared with 44% of individuals with UVF (P = 0.04). Among DCM patients with detectable AIM responses, CD4+ T cells demonstrated an exhausted phenotype with elevated PD-1 expression compared with UVF individuals. In vitro PD-1 blockade augmented IFN-γ production in most tested individuals with DCM.CONCLUSIONThese findings suggest that dissemination may occur in some individuals during a period of impaired antigen-specific T cell activity. Importantly, these responses can be augmented in vitro by PD-1-blocking antibodies, supporting further study of immune checkpoint therapy as an adjunct to antifungal treatment in disseminated coccidioidomycosis.FUNDINGNational Institute of Allergy and Infectious Diseases grants U19 AI166059 and R21 AI149654 and University of California Office of the President grant VFR-19-633386.

Indexed as

CoccidioidesCoccidioidomycosisT-LymphocytesAdultAgedCD4-Positive T-LymphocytesFemaleFlow CytometryHumansMaleMiddle AgedPhenotypeT-Cell ExhaustionFungal infectionsImmunologyImmunotherapyInfectious diseaseT cells

Identifiers

PMID42171605
PMCPMC13232714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.